Anne Phillips, M.D. has been a director since April 2019. In her current role at Novo Nordisk, Dr. Phillips is responsible for medical and regulatory affairs and the clinical development of the Novo Nordisk portfolio of compounds, including product lifecycle initiatives.Prior to Novo Nordisk, Dr. Phillips served in various roles of increasing responsibility from 1998 to 2010 at GlaxoSmithKline plc. Dr. Phillips also served as the Head of the Infectious Diseases Program and Deputy Physician-in-Chief at Wellesley Central Hospital/St. Michael’s Hospital in Toronto, Canada. She is also a director on the board of Trevena, Inc. Dr. Phillips is a Fellow of The Royal College of Physicians and Surgeons of Canada, and earned a medical degree from the University of Toronto and received a Bachelor of Sciences from the University of Western Ontario.